Review preparation and administration information for WINREVAIR™ (sotatercept-csrk), including Instructions for Use (1-vial kit, 2-vial kit) videos.

Learn more about WINREVAIR™ (sotatercept-csrk), review the Patient Information and Instructions for Use (1-vial kit, 2-vial kit).

WINREVAIR is an activin signaling inhibitor indicated for the treatment of adults with pulmonary arterial hypertension (PAH, WHO Group 1) to increase exercise capacity, improve WHO functional...

Before prescribing WINREVAIR, please read the accompanying Prescribing Information. The Patient Information and Instructions for Use (1-vial kit, 2-vial kit) also are available. Indication WINREVAIR is an activin signaling inhibitor indicated for the treatment of …

Mar 26, 2024 · WINREVAIR (sotatercept-csrk) for injection is a white to off-white lyophilized cake or powder appearance supplied in single-dose vials (45 mg or 60 mg) packaged in kits that contain one measuring syringe and one safety needle.

Apr 16, 2024 · Winrevair is supplied in a kit that requires premixing before use. See the package instructions for detailed information about mixing the medicine powder with the sterile water and administering Winrevair. Once mixed, Winrevair should be injected right away, but no later than 4 hours after mixing.

Apr 30, 2024 · How is Winrevair supplied (dosage forms)? Winrevair is available in the following dosage forms that are injected under the skin. 45 mg injection kit; 60 mg injection kit

Patients can find information about how to take WINREVAIR™ (sotatercept-csrk) and frequently asked questions by watching the Instructions for Use videos. The Instructions for Use can also be downloaded.

WINREVAIR is an activin signaling inhibitor indicated for the treatment of adults with pulmonary arterial hypertension (PAH, WHO Group 1) to increase exercise capacity, improve WHO functional class (FC) and reduce the risk of clinical worsening events. (1) ------------------------DOSAGE AND ADMINISTRATION-----------------------

Inject this medication under the skin as directed by your doctor, usually once every 3 weeks. The injection is given in the upper thigh or abdomen (at least 2 inches from your belly button). The dosage is based on your medical condition, labs, weight, and response to treatment.